In addition, real-time quantitative PCR (qPCR) and Western blotting of our in-house prostate tumor and normal tissue samples confirmed that UBC9 was upregulated in tumor tissues as compared with the adjacent normal prostate parts (Figure 1, F and G). This evidence concerns the gene UBE2I and neoplasm.